Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy
Abstract
We conducted a double-blind, controlled trial of low-dose (150 mg/d) oral clindamycin hydrochloride vs placebo to prevent recurrent staphylococcal skin infections. Twenty-two patients (11 in both the placebo and clindamycin treatment groups) completed the trial and were assessable. The two groups di …
Keywords
Administration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
female
male
aged
middle aged
Recurrence
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Random Allocation
neutrophils / physiology
oral
staphylococcal skin infections / prevention & control*
pmid:3184334
m s klempner
b styrt
clindamycin / therapeutic use*
staphylococcal skin infections / drug therapy
staphylococcal skin infections / immunology
Access
Citation
ID:
113900
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
113900
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet